Cited by 2,287Pregnancy and preeclampsia studiesNeurological Complications and SyndromesNeonatal and fetal brain pathology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Open access

Rolnik, Daniel L., Wright, David, Poon, Liona C., O’Gorman, Neil, Syngelaki, Argyro, de Paco Matallana, Catalina, Akolekar, Ranjit, Cicero, Simona, Janga, Deepa, Singh, Mandeep, Molina, Francisca S., Persico, Nicola, Jani, Jacques C., Plasencia, Walter, Papaioannou, George, Tenenbaum-Gavish, Kinneret, Meiri, Hamutal, Gizurarson, Sveinbjorn, Maclagan, Kate, Nicolaides, Kypros H.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704559

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during pregnancy reduces the risk of preterm preeclampsia. METHODS: In this multicenter, double-blind, placebo-controlled trial, we randomly assigned 1776 women with singleton pregnancies who were at high risk for preterm preeclampsia to receive aspirin, at a dose of 150 mg per day, or placebo from 11 to 14 weeks of gestation until 36 weeks of gestation. The primary outcome was delivery with preeclampsia before 37 weeks of gestation. The analysis was performed according to the intention-to-treat principle. RESULTS: A total of 152 women withdrew consent during the trial, and 4 were lost to follow up, which left 798 participants in the aspirin group and 822 in the placebo group. Preterm preeclampsia occurred in 13 participants (1.6%) in the aspirin group, as compared with 35 (4.3%) in the placebo group (odds ratio in the aspirin group, 0.38; 95% confidence interval, 0.20 to 0.74; P=0.004). Results were materially unchanged in a sensitivity analysis that took into account participants who had withdrawn or were lost to follow-up. Adherence was good, with a reported intake of 85% or more of the required number of tablets in 79.9% of the participants. There were no significant between-group differences in the incidence of neonatal adverse outcomes or other adverse events. CONCLUSIONS: Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704559

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Untitled work
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Brown, M. A., Lindheimer, M. D., de SWIET, M., et al. (2001) · Hypertension in Pregnancy · doi:10.3109/10641950109152635 · Cited by 1,369
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J., & Giguère, Y. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,112
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort studyPre-eclampsia and cardiovascular disease later in life: who is at risk?
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Askie, L. M., Duley, L., Henderson-Smart, D. J., & Stewart, L. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60712-0 · Cited by 1,025
Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease
Lisonkova, S., & Joseph, K. S. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.019 · Cited by 926
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679
Self-citation

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: RCOG Press, 2010.
Van Buuren S, 2011, J Stat Softw, 45, 1

Sorted by citations

Items 701–800 of 1,002

The Placenta in Congenital Heart Disease: Form, Function and Outcomes
Josowitz, R., Linn, R. L., & Rychik, J. R. (2023) · NeoReviews · doi:10.1542/neo.24-9-e569 · Cited by 18
Aspirin in Pregnancy
Pullins, M. J., Boggess, K., & Porter, T. F. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005429 · Cited by 18
Early prediction of pre-eclampsia using circulating placental exosomes: Newer insights
Rao, A. A., Shinde, U., Das, D. K., Balasinor, N., & Madan, T. (2023) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_2143_22 · Cited by 18
Reducing the Risk of Pre-Eclampsia in Women with Polycystic Ovary Syndrome Using a Combination of Pregnancy Screening, Lifestyle, and Medical Management Strategies
Parker, J., O'Brien, C. L., Yeoh, C., Gersh, F. L., & Brennecke, S. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061774 · Cited by 21
Pre-eclampsia challenges and care in low and middle-income countries: Understanding diagnosis, management, and health impacts in remote and developing regions
Soundararajan, R., Khan, T., & von Dadelszen, P. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102525 · Cited by 19
Can short‐ and long‐term maternal and infant risks linked to hypertension and diabetes during pregnancy be reduced by therapy?
Stephansson, O., & Sandström, A. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13823 · Cited by 20
Hematologic Complications of Pregnancy
Patel, P. B., Patel, N., Hedges, M. A., Benson, A. E., Tomer, A., Lo, J. O.-T., & Shatzel, J. J. (2025) · European Journal Of Haematology · doi:10.1111/ejh.14372 · Cited by 20
Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for other major defects and pregnancy complications
Kagan, K. O., Sonek, J., Wagner, P., & Hoopmann, M. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4460-3 · Cited by 18
The association of first trimester uterine arteries Doppler velocimetry with different clinical phenotypes of hypertensive disorders of pregnancy: a longitudinal study
Stampalija, T., Monasta, L., Martino, D. D. D., Quadrifoglio, M., Bello, L. L., D’Ottavio, G., Zullino, S., Mastroianni, C., Casati, D., Signorelli, V., et al. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1402878 · Cited by 18
Molecular actions of heparin and their implications in preventing pre‐eclampsia
Wat, J. M. W., Audette, M. C., & Kingdom, J. C. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14191 · Cited by 19
Aspirin pre-treatment modulates ozone-induced fetal growth restriction and alterations in uterine blood flow in rats
Miller, C. N., Kodavanti, U. P., Stewart, E. J., Schaldweiler, M., Richards, J. H., Ledbetter, A. D., Jarrell, L. T., Snow, S. J., Henriquez, A. R., Farraj, A. K., et al. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.12.002 · Cited by 18
Let-7 inhibits the migration and invasion of extravillous trophoblast cell via targeting MDM4
Zhang, L., Wang, K., Wu, Q.-Z., Jin, L., Lü, H., Shi, Y., Liu, L., Yang, L., & Lv, L. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.05.002 · Cited by 18
Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy
Morikawa, M., Kato‐Hirayama, E., Mayama, M., Saito, Y., Nakagawa, K., Umazume, T., Chiba, K., Kawaguchi, S., Okuyama, K., & Watari, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230488 · Cited by 18
Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler
Mendoza, M., Tur, H., García‐Manau, P., Hurtado, I., Serrano, B., López, R. M., Castellote, L., Martínez-Sánchez, L. M., Bonacina, E., & Carreras, E. (2020) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2020.101827 · Cited by 20
Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11–13 weeks of gestation in a Japanese population
Goto, M., Koide, K., Tokunaka, M., Takita, H., Hamada, S., Nakamura, M., Matsuoka, R., Sekizawa, A., & Poon, L. C. (2020) · Hypertension Research · doi:10.1038/s41440-020-00571-4 · Cited by 18
Self-citation
Defining the risk profile of women with stage 1 hypertension: a time to event analysis
Sabol, B., Porcelli, B. A., Diveley, E., Meyenburg, K., Woolfolk, C., Rosenbloom, J. I., Raghuraman, N., & Stout, M. J. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100376 · Cited by 18
Obstetric anti-phospholipid syndrome: from pathogenesis to treatment
Kaneko, K., Ozawa, N., & Murashima, A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1969116 · Cited by 18
Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study
Poon, L. C., Wright, D. E., Thornton, S., Akolekar, R., Brocklehurst, P., & Nicolaides, K. H. (2020) · Efficacy and Mechanism Evaluation · doi:10.3310/eme07080 · Cited by 19
Self-citation
First Trimester Preeclampsia Screening and Prevention: Perspective in Chinese Mainland
Liu, J., Chen, Y., Tai, S. T. A., Nguyen‐Hoang, L., Li, K., Lin, J., Lu, X., & Poon, L. C. (2024) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000215 · Cited by 17
Self-citation
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Mahadevan, U., Seow, C. H., Barnes, E. L., Chaparro, M., Flanagan, E. K., Friedman, S., Julsgaard, M., Kane, S. V., Ng, S. C., Torres, J., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003651 · Cited by 17
Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
Prins, J. R., Holvast, F., Hooft, J. V. ’., Bos, A. F., Ganzevoort, W., Scherjon, S. A., Robertson, S. A., & Gordijn, S. J. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021619 · Cited by 17
Impact on perinatal health and cost-effectiveness of risk-based care in obstetrics: a before-after study
van Montfort, P., Scheepers, H. C. J., Dirksen, C. D., van Dooren, I. M. A., van Kuijk, S. M. J., Meertens, L. J. E., Wijnen, E. J., Zelis, M., Zwaan, I. M., Spaanderman, M. E. A., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.02.036 · Cited by 17
Receipt of Proton-Pump Inhibitors during Pregnancy and Risk for Preeclampsia
Bello, N. A., Huang, Y., Syeda, S. K., Wright, J. D., D’Alton, M. E., & Friedman, A. M. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1713864 · Cited by 17
Stratification of pregnancy care based on risk of pre‐eclampsia derived from biophysical and biochemical markers at 19–24 weeks' gestation
Litwińska, M., Litwińska, E., Astudillo, A., Syngelaki, A., Wright, A., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23640 · Cited by 17
Self-citation
Optimising Women’s Cardiovascular Health After Hypertensive Disorders of Pregnancy: A Translational Approach to Cardiovascular Disease Prevention
Nerenberg, K. A., Cooke, C. M., Smith, G. N., & Davidge, S. T. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.08.007 · Cited by 17
The Hypertensive Disorders of Pregnancy: A Focus on Definitions for Clinical Nephrologists
Longhitano, E., Siligato, R., Torreggiani, M., Attini, R., Masturzo, B., Casula, V., Matarazzo, I., Cabiddu, G., Santoro, D., Versino, E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123420 · Cited by 17
Practical guide for the management of hypertensive disorders during pregnancy
Antza, C., Stabouli, S., & Kotsis, V. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003194 · Cited by 17
Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical‐length measurement at 19–25 weeks' gestation
Maymon, R., Pekar‐Zlotin, M., Meiri, H., Haklai, Z., Gordon, E. ‐., Shlichkov, G., & Cuckle, H. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26093 · Cited by 17
Self-citation
The Implementation of Preeclampsia Screening and Prevention (IMPRESS) Study
Johnson, J.-A., Walsh, J. D., Okun, N. B., Metcalfe, A., Pastuck, M., Maxey, C., Soliman, N., Mahallati, H., Kuret, V., Dwinnell, S. J., et al. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100815 · Cited by 17
Hyperuricemia during Pregnancy Leads to a Preeclampsia-Like Phenotype in Mice
Lüscher, B. P., Schoeberlein, A., Surbek, D., & Baumann, M. U. (2022) · Cells · doi:10.3390/cells11223703 · Cited by 17
Meta-Analysis of Cardiovascular Risk Factors in Offspring of Preeclampsia Pregnancies
Wang, W., Lin, R., Yang, L., Wang, Y., Mao, B., Xu, X., & Yu, J. (2023) · Diagnostics · doi:10.3390/diagnostics13040812 · Cited by 17
Placental syndromes and maternal cardiovascular health
Casey, H., Dennehy, N., Fraser, A., Lees, C., McEniery, C. M., Scott, K., Wilkinson, I. B., & Delles, C. (2023) · Clinical Science · doi:10.1042/cs20211130 · Cited by 18
High-Sensitivity Cardiac Troponin I Enhances Preeclampsia Prediction Beyond Maternal Factors and the sFlt-1/PlGF Ratio
Bacmeister, L., Goßling, A., Buellesbach, A., Birukov, A., Myers, J., Thomas, S. T., Lee, S., Andersen, M., Jørgensen, J. S., Diemert, A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066199 · Cited by 18
Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation
Chaemsaithong, P., Biswas, M., Lertrut, W., Warintaksa, P., Wataganara, T., Poon, L. C., & Sukasem, C. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102437 · Cited by 17
Self-citation
Thrombocytes and Platelet-Rich Plasma as Modulators of Reproduction and Fertility
Nagy, B., Kovács, K. A., Sulyok, E., Várnagy, Á., & Bódis, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417336 · Cited by 17
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach
Joshi, E., Gibson, P. G., McDonald, V. M., & Murphy, V. E. (2023) · European Respiratory Review · doi:10.1183/16000617.0105-2023 · Cited by 18
Predicting intensive care need in women with preeclampsia using machine learning – a pilot study
Edvinsson, C., Björnsson, O., Erlandsson, L., & Hansson, S. R. (2024) · Hypertension in Pregnancy · doi:10.1080/10641955.2024.2312165 · Cited by 17
Prophylactic Aspirin Dose and Preeclampsia
Kupka, E., Hesselman, S., Gunnarsdóttir, J., Wikström, A., Cluver, C. A., Tong, S., Hastie, R. M., & Bergman, L. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.57828 · Cited by 17
Low-Dose Aspirin for the Prevention of Preeclampsia
Fantasia, H. C. (2018) · Nursing for Women s Health · doi:10.1016/j.nwh.2017.12.002 · Cited by 17
Trends in comorbidity, acuity, and maternal risk associated with preeclampsia across obstetric volume settings
Booker, W. A., Ananth, C. V., Wright, J. D., Siddiq, Z., D’Alton, M. E., Cleary, K. L., Goffman, D., & Friedman, A. M. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1446077 · Cited by 17
Principales conclusiones del Consenso Argentino de Hipertensión Arterial
Delucchi, A., Marin, M., Paez, O. B., Bendersky, M., & Rodríguez, P. (2019) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2019.01.001 · Cited by 18
Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol
Langston‐Cox, A., Marshall, S. A., Palmer, K. R., & Wallace, E. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027493 · Cited by 17
Differential levels of surfactant protein A, surfactant protein D, and progesterone to estradiol ratio in maternal serum before and after the onset of severe early‐onset preeclampsia
Kale, K., Vishwekar, P. S., Balsarkar, G. D., Jassawalla, M., Sawant, G., & Madan, T. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13208 · Cited by 17
Acetylsalicylic acid rescues the immunomodulation of inflamed gingiva-derived mesenchymal stem cells via upregulating FasL in mice
Yu, T., Yan, B., Li, J., Zhang, T., Yang, R., Wang, X., Liu, Y., & Liu, D. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1485-5 · Cited by 17
Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women
Naseem, H., Dreixler, J. C., Mueller, A., Tung, A., Dhir, R., Chibber, R., Fazal, A. A., Granger, J. P., Bakrania, B. A., deMartelly, V. A., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015997 · Cited by 17
The 15-Epilipoxin-A4 Pathway with Prophylactic Aspirin in Preventing Preeclampsia: A Longitudinal Cohort Study
Shanmugalingam, R., Wang, X., Motum, P., Fulcher, I., Lee, G., Kumar, R., Hennessy, A., & Makris, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa642 · Cited by 17
Special considerations regarding antenatal care and pregnancy complications in dichorionic twin pregnancies
Hiersch, L., Attali, E., & Melamed, N. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100500 · Cited by 17
Clinical Applications of Aspirin as a Multi-potent Drug Beyond Cardiovascular Implications: A Proof of Concept for Anesthesiologists- A Narrative Review
Rezabakhsh, A., Mahmoodpoor, A., Soleimanpour, M., Shahsavarinia, K., & Soleimanpour, H. (2021) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.118909 · Cited by 17
Hipertensión arterial y embarazo
Múnera, A. G., Muñoz-Ortiz, E., & Burgos, J. A. I. (2021) · Revista Colombiana de Cardiología · doi:10.24875/rccar.m21000002 · Cited by 17
A Review of the Best Practice Guide 2021 for the Diagnosis and Management of Hypertensive Disorders of Pregnancy (HDP)
(2022) · Hypertension Research in Pregnancy · doi:10.14390/jsshp.10.57 · Cited by 17
Medications for preventing hypertensive disorders in high-risk pregnant women: a systematic review and network meta-analysis
Liabsuetrakul, T., Yamamoto, Y., Kongkamol, C., Ota, E., Mori, R., & Noma, H. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01978-5 · Cited by 17
Down-regulation of DKK1 and Wnt1/β-catenin pathway by increased homeobox B7 resulted in cell differentiation suppression of intrauterine fetal growth retardation in human placenta
Huang, L., Ying, H., Chen, Z., Zhu, Y., Gu, Y., Hu, L., Chen, D., & Zhong, N. A. (2019) · Placenta · doi:10.1016/j.placenta.2019.03.001 · Cited by 17
Kidney disease and reproductive health
Smith, P., Sarris, I., Clark, K., Wiles, K., & Bramham, K. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00901-6 · Cited by 16
Predicting preeclampsia in early pregnancy using clinical and laboratory data via machine learning model
Chen, S., Li, J., Zhang, X., Xu, W., Qiu, Z., Yan, S., Zhao, W., Zhao, Z., Tian, P., Zhao, Q., et al. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02999-5 · Cited by 16
Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy
Zhang, Y., Liu, X., Yang, L., & Zou, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.596145 · Cited by 16
Low-dose aspirin in pregnancy: who? when? how much? and why?
Mather, A., Dom, A. M., & Thorburg, L. L. (2021) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000694 · Cited by 16
Development of early prediction model for pregnancy-associated hypertension with graph-based semi-supervised learning
Lee, S. M., Nam, Y., Choi, E. S., Jung, Y. M., Sriram, V., Leiby, J. S., Koo, J. N., Oh, I. H., Kim, B. J., Kim, S. M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15391-4 · Cited by 16
Risk of recurrent severe maternal morbidity: a population-based study
Ukah, U. V., Platt, R. W., Auger, N., Lisonkova, S., Ray, J. G., Malhamé, I., Ayoub, A., El‐Chaâr, D., & Dayan, N. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.06.010 · Cited by 16
First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth
Nicolaides, K. H., Syngelaki, A., Poon, L. C., Rolnik, D. L., Tan, M. Y., Wright, A., & Wright, D. E. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17673 · Cited by 16
Self-citation
La pré-éclampsie : recommandations pour la pratique clinique du Collège national des gynécologues obstétriciens français
Sentilhes, L., Schmitz, T., Arthuis, C., Barjat, T. R., Berveiller, P., Camilleri, C., Froeliger, A., Garabédian, C., Guerby, P., Korb, D., et al. (2023) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2023.10.002 · Cited by 17
Prediction and prevention of preterm birth: Quality assessment and systematic review of clinical practice guidelines using the AGREE II framework
Ramachandran, A., Clottey, K. D., Gordon, A., & Hyett, J. A. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15514 · Cited by 18
Secondary prevention of preeclampsia
Akbar, M. I. A., Rosaudyn, R., Gumilar, K. E., Shanmugalingam, R., & Dekker, G. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1520218 · Cited by 16
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial
Furuhashi, F. H., Tanaka, H., Maki, S., Tsuji, M., Magawa, S., Kaneda, M. K., Nii, M., Tanaka, K., Ogura, T., Nishimura, Y., et al. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1690447 · Cited by 16
First-trimester screening-biomarkers and cell-free DNA
Suciu, I. D., Galeva, S., Azim, S. A., Pop, L. G., & Toader, O. D. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1698031 · Cited by 16
Pathophysiology of the Venous Thromboembolism Risk in Preeclampsia
Kelliher, S., Maguire, P. B., Szklanna, P. B., Weiß, L., Ewins, K., O’Doherty, R., Angelov, D., Áinle, F. N., & Kevane, B. (2020) · Hämostaseologie · doi:10.1055/a-1162-3905 · Cited by 16
A Multi-Objective Approach for Drug Repurposing in Preeclampsia
Tejera, E., Pérez‐Castillo, Y., Chamorro, A., Cabrera‐Andrade, A., & Sánchez, M. E. (2021) · Molecules · doi:10.3390/molecules26040777 · Cited by 16
Doppler ultrasound in pregnancy – quality requirements of DEGUM and clinical application (part 2)
Faber, R., Heling, K., Steiner, H., & Gembruch, U. (2021) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/a-1452-9898 · Cited by 16
Ophthalmic artery peak systolic velocity ratio distinguishes pre‐eclampsia from chronic and gestational hypertension: A prospective cohort study
Lau, K. G. Y., Wright, A., Kountouris, E., Nicolaides, K. H., & Kametas, N. A. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17061 · Cited by 16
Self-citation
Association between trace elements and preeclampsia: A retrospective cohort study
Chen, Y., Ou, Q. X., Chen, Y., Zhu, Q. L., Tan, M. H., Zhang, M. M., Wu, S. Z., & Xu, H. Y. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.126971 · Cited by 16
Impact of replacing or adding pregnancy‐associated plasma protein‐A at 11–13 weeks on screening for preterm pre‐eclampsia
Wah, Y. M. I., Sahota, D. S., Chaemsaithong, P., Wong, L., Kwan, A. H. W., Ting, Y. H., Law, K. M., Leung, T. Y., & Poon, L. C. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.24918 · Cited by 16
Self-citation
Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention
Phelps, A. J. D., & Holmgren, C. M. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06773-0 · Cited by 16
Podocyturia as an early diagnostic marker of preeclampsia: a literature review
Panek–Laszczyńska, K., Konieczny, A., Milewska, E., Dąbrowska, K., Bąchor, R., Witkiewicz, W., & Szewczuk, Z. (2017) · Biomarkers · doi:10.1080/1354750x.2017.1405283 · Cited by 16
THE COMMITTEE OF EXPERTS OF THE RUSSIAN SOCIETY OF CARDIOLOGY (RSC). SECTION OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN. NATIONAL GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY 2018. NEW REVISION: JULY, 2018 (TEXT IS AVAILABLE IN ELECTRONIC VERSION)
Editorial, A. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-7-156-200 · Cited by 16
Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial
for the PETN Study Group, Groten, T., Lehmann, T., & Schleußner, E. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2456-7 · Cited by 16
Performance of a first-trimester combined screening for preterm preeclampsia in the United States population using the fetal medicine foundation competing risks model
Martins, J. G., Miller, E. P., Aboukhater, D., Bittner, M. L., Rolnik, D. L., & Kawakita, T. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101803 · Cited by 17
Self-citation
Redefining pre‐eclampsia as Type I or II : implementing an integrated model of the maternal‐cardiovascular–placental–fetal array
Yagel, S., Cohen, S. M., Goldman‐Wohl, D., & Beharier, O. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26121 · Cited by 15
Fetal Growth Restriction Is Associated with Pregnancy Associated Plasma Protein A and Uterine Artery Doppler in First Trimester
Springer, S., Worda, K., Franz, M., Karner, E., Krampl‐Bettelheim, E., & Worda, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072502 · Cited by 17
Incremental predictive value of platelet parameters for preeclampsia: results from a large prospective cohort study
Lin, S., Wang, C., Wei, D., Lu, J., Chen, X., Chen, Q., Xia, X., He, J., & Qiu, X. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05661-y · Cited by 15
Glycosylated fibronectin improves first‐trimester prediction of pre‐eclampsia
Moungmaithong, S., Wang, X., Lau, C. S. L., Tse, W. T., Lee, N., Leung, H. H. Y., Poon, L. C., & Sahota, D. S. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.27451 · Cited by 15
Self-citation
Obstetric antiphospholipid syndrome
Soto-Peleteiro, A., González-Echávarri, C., & Ruiz‐Irastorza, G. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.05.001 · Cited by 15
Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling
Baetens, M., Gaever, B. V., Deblaere, S., Koker, A. D., Meuris, L., Callewaert, N., Janssens, S., Roelens, K., Roets, E., Dorpe, J. V., et al. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01798-5 · Cited by 15
The Effect of Low-Dose Aspirin on Disease Activity in Pregnant Individuals With Inflammatory Bowel Disease
Memel, Z. N., Yu, A., Fenton, C. L., Wen, T., Irani, R. A., Zhang, L., & Mahadevan, U. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003304 · Cited by 15
Management of hypertension in pregnancy — prevention, diagnosis, treatment and long-term prognosis. A position statement of the Polish Society of Hypertension, Polish Cardiac Society and Polish Society of Gynaecologists and Obstetricians
Prejbisz, A., Dobrowolski, P., Kosiński, P., Bomba-Opon, D. A., Adamczak, M., Bekiesińska‐Figatowska, M., Kądziela, J., Konopka, A., Kostka-Jeziorny, K., Kurnatowska, I., et al. (2019) · Arterial Hypertension · doi:10.5603/ah.a2019.0011 · Cited by 15
Implementing a Preeclampsia Prediction Model in Obstetrics: Cutoff Determination and Health Care Professionals’ Adherence
van Montfort, P., Smits, L. J. M., van Dooren, I. M. A., Lemmens, S. M. P., Zelis, M., Zwaan, I. M., Spaanderman, M. E. A., & Scheepers, H. C. J. (2019) · Medical Decision Making · doi:10.1177/0272989x19889890 · Cited by 15
The antithrombin binding regions of heparin mediate fetal growth and reduced placental damage in the RUPP model of preeclampsia†
Wat, J. M. W., Baczyk, D., & Kingdom, J. C. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa006 · Cited by 15
Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein
Hu, J., Zhang, Y., Zhang, J., Zhu, S., Li, D., Yin, Y., Su, J., Chan, Y., He, J., Cao, Y.-J., et al. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.11.011 · Cited by 15
Using Supervised Learning Methods to Develop a List of Prescription Medications of Greatest Concern during Pregnancy
Ailes, E. C., Zimmerman, J., Lind, J. N., Fan, F., Shi, K., Reefhuis, J., Broussard, C. S., Frey, M. T., Cragan, J. D., Petersen, E. E., et al. (2020) · Maternal and Child Health Journal · doi:10.1007/s10995-020-02942-2 · Cited by 15
Hemodynamic Complications in Pregnancy
Doherty, A., McLaughlin, K., & Kingdom, J. C. (2020) · Clinics in Perinatology · doi:10.1016/j.clp.2020.05.014 · Cited by 15
Screening for trisomy at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A , placental growth factor or both
Zumaeta, A. M., Wright, A., Syngelaki, A., Maritsa, V., Bardani, E., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22140 · Cited by 15
Self-citation
Serum proteins differentially expressed in early- and late-onset preeclampsia assessed using iTRAQ proteomics and bioinformatics analyses
Tu, C., Tao, F., Qin, Y., Wu, M., Cheng, J. H., Xie, M., Shen, B. Q., Ren, J., Xu, X., Huang, D., et al. (2020) · PeerJ · doi:10.7717/peerj.9753 · Cited by 15
Technologies for Prediction of Preeclampsia
Rokotyanskaya, E. A., Панова, И. А., Malyshkina, A. I., Николаевна, Ф. И., Fetisov, N. S., Kharlamova, N. V., & Кулигина, М. В. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.5.09 · Cited by 15
Recurrence Risk of Fetal Growth Restriction
Blue, N. R., Pagé, J., & Silver, R. M. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.03.002 · Cited by 15
Pregnancy and CKD: Advances in Care and the Legacy of Dr Susan Hou
Oliverio, A. L., Bramham, K., & Hladunewich, M. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.07.016 · Cited by 15
Preeclampsia: Maternal cardiovascular function and optimising outcomes
Dennehy, N., & Lees, C. C. (2022) · Early Human Development · doi:10.1016/j.earlhumdev.2022.105669 · Cited by 15
Evidence-based management of pregnant women with sickle cell disease in high-income countries
Oteng‐Ntim, E., & Shangaris, P. (2022) · Hematology · doi:10.1182/hematology.2022000378 · Cited by 15
Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study
Lailler, G., Grave, C., Gabet, A., Regnault, N., Deneux‐Tharaux, C., Kretz, S., Tsatsaris, V., Plu‐Bureau, G., Blacher, J., & Olié, V. (2023) · Drugs · doi:10.1007/s40265-023-01842-3 · Cited by 15
Hypertensive states of pregnancy
González, E. R., Arroyo, A. M. H., Benasach, F. G., & Conde, T. G. (2024) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2023.11.006 · Cited by 17
Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients With Impaired PP13 Molecule or Function
Meiri, H., Osol, G., Cetin, I., Gizurarson, S. S., & Huppertz, B. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2017.09.002 · Cited by 15
Self-citation
Stroke in Women
Kaplovitch, E., & Anand, S. S. (2018) · Stroke · doi:10.1161/strokeaha.117.020354 · Cited by 15
Österreichischer Blutdruckkonsens 2019
Hypertensiologie, Ö. G. F., Weber, T., Atherosklerosegesellschaft, Ö., Gesellschaft, Ö. D., Angiologie, Ö. G. F. I., Nephrologie, Ö. G. F., Gesellschaft, Ö. K., Neurologie, Ö. G. F., Schlaganfall-Gesellschaft, Ö., Allgemeinmedizin, Ö. G. F., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01565-0 · Cited by 15

Authors: Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H.
Affiliations: Université Libre de Bruxelles (BE)
King's College Hospital (GB)
ORCID: Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O’Gorman, Neil
Syngelaki, Argyro
Akolekar, Ranjit
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Meiri, Hamutal
Maclagan, Kate
Nicolaides, Kypros H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-17
Volume: 377
Issue: 7
Pages: 613-622
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704559
OpenAlex: W2730504020
Cited by: 2,287
References: 24
Citations by year: 2026: 252 · 2025: 277 · 2024: 231 · 2023: 274 · 2022: 257 · 2021: 249 · 2020: 265 · 2019: 212 · 2018: 196 · 2017: 69
FWCI: 238.94
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (publishedVersion, other-oa)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
Funders: Imperial College London
Imperial College Healthcare NHS Trust
University College London
European Commission (FP7-HEALTH-2013INNOVATION, 601852, HEALTH-2013)
Fetal Medicine Foundation
FP7 Health (601852)
Topics: Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
Keywords: low-dose aspirin, preterm preeclampsia, high-risk pregnancy, preeclampsia prevention, singleton pregnancy, drug safety in pregnancy, adverse neonatal outcomes
MeSH terms: Adult, Aspirin, Double-Blind Method, Female, Humans, Infant, Newborn, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Risk, Incidence, Kaplan-Meier Estimate, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks